T-Cell Phenotypes Predictive of Frailty and Mortality in Elderly Nursing Home Residents

Journal of the American Geriatrics Society

Volumn 65, Issue 1, 2017, Pages 153-159

  Johnstone, Jennie ^a,b   Parsons, Robin ^c   Botelho, Fernando ^c   Millar, Jamie ^c   McNeil, Shelly ^d   Fulop, Tamas ^e   McElhaney, Janet E ^f   Andrew, Melissa K ^g   Walter, Stephen D ^a   Devereaux, P J ^a   Malek, Mehrnoush ^h   Brinkman, Ryan R ^h,i   Bramson, Jonathan ^a,c   Loeb, Mark ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b PUBLIC HEALTH ONTARIO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

^f HEALTH SCIENCES NORTH   (Canada)

^g DALHOUSIE UNIVERSITY   (Canada)

^h BRITISH COLUMBIA CANCER AGENCY   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

frailty; immune biomarker; immunosenescence; mortality; nursing home

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CYTOMEGALOVIRUS ANTIGEN PP65; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER;

AGE; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; CYTOMEGALOVIRUS; EFFECTOR CELL; ELDERLY CARE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; FRAILTY; HUMAN; IMMUNOPHENOTYPING; IMMUNOSENESCENCE; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; MORTALITY; NURSING HOME; NURSING HOME PATIENT; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE; REGULATORY T LYMPHOCYTE; SEX; VERY ELDERLY; BLOOD; CANADA; EPIDEMIOLOGY; FRAIL ELDERLY; IMMUNOLOGY; METABOLISM; MULTIVARIATE ANALYSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOMARKERS; CANADA; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS; FEMALE; FRAIL ELDERLY; HUMANS; IMMUNOSENESCENCE; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NURSING HOMES;

EID: 84999748052     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.14507     Document Type: Article

References (41)

1. Fulop T, Larbi A, Wikby A et al. Dysregulation of T-cell function in the elderly: Scientific basis and clinical implications. Drugs Aging 2005;22:589–603.
2. Saule P, Trauet J, Dutriez V et al. Accumulation of memory T cells from childhood to old age: Central and effector memory cells in CD4+ versus effector memory and terminally differentiated memory cells in CD8+ compartment. Mech Ageing Dev 2006;127:274–281.
3. Fahey J, Schnelle J, Boscardin J et al. Distinct categories of immunologic changes in frail elderly. Mech Ageing Dev 2000;115:1–20.
4. Effros R, Boucher N, Porter V et al. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: A possible cause for both in vivo and in vitro immunosenecence. Exp Gerontol 1994;29:601–609.
5. Boucher N, Dufeu-Duchesne T, Vicaut E et al. CD28 expression in T cell aging and human longevity. Exp Gerontol 1998;33:267–282.
6. Pawelec G, Larbi A, Derhovanessian E. Senescence of the human immune system. J Comp Pathol 2010;142:S39–S44.
7. Wikby A, Maxson P, Olsson J et al. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: The Swedish longitudinal OCTO-immune study. Mech Ageing Dev 1998;102:187–198.
8. Olsson J, Wikby A, Johansson B et al. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: The Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000;121:187–201.
9. Wikby A, Johansson B, Olsson J et al. Expansion of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: The Swedish NONA immune study. Exp Gerontol 2002;37:445–453.
10. Ferrando-Martinez S, Romero-Sanchez M, Solana R et al. Thymic function failure and C-reactive protein levels are independent predictors of all-cause mortality in healthy elderly humans. Age 2013;35:251–259.
11. Huppert F, Pinto E, Morgan K et al. Survival in a population sample is predicted by proportions of lymphocyte subsets. Mech Ageing Dev 2003;124:449–451.
12. Semba R, Margolick J, Leng S et al. T cell subsets and mortality in older community-dwelling women. Exp Gerontol 2005;40:81–87.
13. Wang G, Kao W, Murakami P et al. Cytomegalovirus infection and the risk of mortality and frailty in older women: A prospective observational cohort study. Am J Epidemiol 2010;171:1144–1152.
14. Mathei C, Vaes B, Wallemacq P et al. Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL cohort. J Am Geriatr Soc 2011;59:2201–2208.
15. Collerton J, Martin-Ruiz C, Davies K et al. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: Cross-sectional findings from the Newcastle 85+ study. Mech Ageing Dev 2012;133:456–466.
16. Rockwood K, Abeysundera M, Mitnitski A. How should we grade frailty in nursing home patients? J Am Med Dir Assoc 2007;8:595–603.
17. Johnstone J, Parsons R, Botelho F et al. Immune biomarkers predictive of respiratory viral infection in elderly nursing home residents. PLoS ONE 2014;9:e108481.
18. Searle S, Mitnitski A, Gahbauer E et al. A standard procedure for creating a frailty index. BMC Geriatrics 2008;8:24.
19. Disis M, dela Rosa C, Goodell V et al. Maximizing the retention of antigen specific lymphocyte function after cryopreservation. J Immunol 2006;308:13–18.
20. Lelic A, Verschoor CP, Ventresca M et al. The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age. PLoS Pathog 2012;8:e1003076.
21. Verschoor CP, Johnstone J, Millar J et al. Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer. J Leukoc Biol 2013;93:633–637.
22. Malek M, Taghiyar MJ, Chong L et al. flowDensity: Reproducing manual gating of flow cytometry data by automated density-based cell population identification. Bioinformatics 2015;31:606–607.
23. Marshall A, Altman DG, Holder RL. Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model: A resampling study. BMC Med Res Methodol 2010;31:112.
24. Localio A, Berlin J, Ten Have T et al. Adjustments for center in multicenter studies: An overview. Ann Intern Med 2001;135:112–123.
25. Chu R, Thabane L, Ma J et al. Comparing methods to estimate treatment effects on a continuous outcome in multicentre randomized controlled trials: A simulation study. BMC Med Rese Methodol 2011;11:21.
26. Fulop T, Larbi A, Witkowski J et al. Aging, frailty and age-related disease. Biogerontology 2010;11:547–563.
27. Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol 2007;17:227–236.
28. Wei L, Lin D, Weissfeld L. Regression-analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989;84:1065–1073.
29. Fox J, The R. Commander: A basic statistics graphical user interface to R. J Stat Softw 2005;14:1–42.
30. O'Shea J, Paul W. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T-cells. Science 2010;327:1098–1102.
31. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T-cell subsets: Function, generation and maintenance. Annu Rev Immunol 2004;22:745–763.
32. Mathei C, Adriaensen W, Vaes B et al. No relation between CMV infection and mortality in the oldest old: Results from the Befrail Study. Age Ageing 2015;44:130–135.
33. Vescovini R, Biasini C, Telera A et al. Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J Immunol 2010;184:3242–3249.
34. Sester M, Sester U, Gartner B et al. Levels of virus-specific CD4 T-cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 2001;71:1287–1294.
35. Pourgheysari B, Khan N, Best D et al. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol 2007;81:7759–7765.
36. Wertheimer A, Bennett M, Park B et al. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol 2014;192:2143–2155.
37. Pachnio A, Begum J, Fox A et al. Acyclovir therapy reduces the CD4+ T-cell response against the immunodominant pp65 protein from cytomegalovirus in immune competent individuals. PLoS ONE 2015;10:e0125287.
38. Ouyang Q, Wagner W, Wikby A et al. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol 2003;23:247–257.
39. Khan N, Shariff N, Cobbold M et al. Cytomegaolvirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy individuals. J Immunol 2002;169:1984–1992.
40. Ferrando-Martinez S, Ruiz-Mateos E, Casazza J et al. IFNγ-TFNα-IL2-MIP1α-CD107a+PRF1+ CD8 pp65-specific T-cell response is independently associated with time to death in elderly humans. J Gerontol A Biol Sci Med Sci 2015;70A:1210–1218.
41. Sylwester A, Mitchell B, Edgar J et al. Broadly targeted human cytomegalovirus specific CD4+ and CD8+ T-cells dominate the memory compartments of exposed subjects. J Exp Med 2005;202:673–685.